{"nct_id":"NCT04171843","title":"A Dose-escalation Study to Evaluate the Safety and Clinical Activity of PBCAR269A, With or Without Nirogacestat, in Study Participants With Relapsed/Refractory Multiple Myeloma","status":"TERMINATED","status_verified_date":"2023-09","start_date":"2020-04-30","start_date_type":"ACTUAL","primary_completion_date":"2022-10-19","primary_completion_date_type":"ACTUAL","completion_date":"2022-10-19","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["DTIL"]}